DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meprobamate (Meprobamate) - Summary



Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.

Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

See all Meprobamate indications & dosage >>


Media Articles Related to Meprobamate

Anxiety Levels Highest at Mid Management in Workplace
Source: Medscape Psychiatry & Mental Health Headlines [2015.08.28]
Supervisors, managers show higher prevalence of anxiety compared with either higher- or lower-ranking colleagues.
Medscape Medical News

Majority of false-positive mammograms associated with anxiety, distress
Source: Anxiety / Stress News From Medical News Today [2015.08.26]
Researchers have found that patients who receive false-positive mammogram results are significantly more likely to report negative psychosocial consequences than those who do not.

Music may reduce pain, anxiety after surgery
Source: Anxiety / Stress News From Medical News Today [2015.08.13]
Patients who listened to music before, during or after surgery experienced a reduction in pain and anxiety after the procedure and were less likely to need pain medication.

Depression, stress, anxiety and anger compound risk of cardiovascular disease in RA patients
Source: Anxiety / Stress News From Medical News Today [2015.08.13]
New research reveals that depressive symptoms, stress, anxiety, and anger and lack of social support in patients with rheumatoid arthritis (RA) were linked to atherosclerosis - a build-up of fatty...

Generalized anxiety disorders twice as likely in those with inflammatory bowel disease
Source: Pain / Anesthetics News From Medical News Today [2015.07.30]
Study finds generalized anxiety disorder is much more common among individuals with Crohn's disease or ulcerative colitisPeople who have inflammatory bowel disease (IBD), such as Crohn's disease...

more news >>

Published Studies Related to Meprobamate

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).

more studies >>

Reports of Suspected Meprobamate Side Effects

Toxicity TO Various Agents (28)Respiratory Arrest (15)Cardiac Arrest (15)Accidental Death (14)Drug Abuse (11)Completed Suicide (11)Death (5)Multiple Drug Overdose Accidental (5)Pulmonary Congestion (5)Pulmonary Oedema (4)more >>

Page last updated: 2015-08-28

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015